Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder

NCT06250543 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: AbobotulinumtoxinA 300 UNT
DRUG: IncobotulinumtoxinA 100 UNT
DRUG: Lidocain
OTHER: placebo

Sponsor

Niko Kavcic